The Byos platform Intact workflow offers efficient identification, inspection, and relative quantification of charge variants, while reliably detecting even the low abundance species and highlighting even subtle differences between innovator and biosimilar products.
Lab of the Future - Fully Automated High Throughput Mass Spectrometry for BiotherapeuticsHere we describe a state-of-the-art, integrated, multi-instrument automated system designed to execute methods involved in mass spectrometry characterization of biotherapeutics, as implemented at Janssen.
The Byos HDX workflow makes it easy to analyze complex deuterium ratio calculations and visualize the results, helping to reduce analysis time
ASMS 2023: Investigations of a Bispecific Antibody Dimerization via Hydroxyl Radical FootprintingAuthors report how PLIMB can be used to understand potential mechanism for bsAb aggregate formation using a tool molecule from clarified culture harvest
Raw MS data and associated meta data are swept to an automation module in Byosphere that resides in the J&J cloud server.
Advanced querying capabilities and quality control of data allows triaging voluminous data sets
Here we describe a state-of-the-art, integrated, multi-instrument automated system designed to execute methods involved in mass spectrometry characterization of biotherapeutics, as implemented at Janssen.
Combining OBE nMS with PMI software enables rapid analysis of masses, binding partners, and stoichiometries of designed protein assemblies
ASMS 2023: Effects of Fab glycosylation on anti - SARS - CoV - 2 antibody - antigen binding assessed by SEC and LC - MSStudy of anti-spike protein (SARS-CoV-2) blocking mAbs with a focus on measuring Fab glycosylation and its impact on binding to spike protein antigens